High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: A study in a land of low high-density lipoprotein cholesterol

References

• Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TRl. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977;62: 707–14.
   PubMed Web of Science ®Google Scholar
• Onat A, Keles I, Cetinkaya A, Basar O. Prevalence of coronary mortality and morbidity in the Turkish adult risk factor study: 10-year follow-up suggests coronary epidemic. Arch Turk Soc Cardiol 2001;29:8–19.
   Google Scholar
• Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois A-M, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Özbayrakçı S, Gökdemir O, Winkler W. 1995. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res36:839–59.
   PubMed Web of Science ®Google Scholar
• Kontush A, Chapman MJ. Antiatherogenic small, dense HDL – guardian angel of the arterial wall?Nat Clin Pract Cardiovasc Med 2006;3:144–53.
   PubMedGoogle Scholar
• Asztalos B, Zhang W, Roheim PS, Wong L. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 1997;17:1630–6.
   Google Scholar
• Yoshikawa M, Sakuma N, Hibino T, Sato T, Fujinami T. HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. Clin Biochem 1997;30:221–5.
   Google Scholar
• Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003;23: 1881–8.
   PubMed Web of Science ®Google Scholar
• Ashby DT, Rye KA, Clay MA, Vadas MA, Gamble JR, Barter PJ. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:1450–5.
   PubMed Web of Science ®Google Scholar
• Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Cui R, Tanigawa T, Sankai T, Ishikawa Y, Sato S, Hitsumoto S, Iso H; CIRCS Investigators. High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population: the circulatory risk in communities study. Stroke 2013;44:327–33.
   Google Scholar
• Kempen HJ, van Gent CM, Buytenhek R, Buis B. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. J Lab Clin Med 1987;109:19–26.
   PubMed Web of Science ®Google Scholar
• Smuts CM, Weich HF, Weight MJ, Faber M, Kruger M, Lombard CJ, Benade AJ. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease. Coron Artery Dis 1994;5:331–8.
   Google Scholar
• Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 1997;17:1098–105.
   PubMed Web of Science ®Google Scholar
• Miller NE, Hammett F, Saltissi S, Rao S, van Zeller H, Coltart J, Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. BMJ 1981;282:1741–4.
   PubMed Web of Science ®Google Scholar
• Calabresi L, Franceschini G, Sirtori M, Gianfranceschi G, Werba P, Sirtori CR. Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease. Atherosclerosis 1990;84:41–8.
   Google Scholar
• Syvanne M, Ahola M, Lahdenpera S, Kahri J, Kuusi T, Virtanen KS, Taskinen MR. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 1995;36:573–82.
   PubMed Web of Science ®Google Scholar
• Miller NE, Førde OH, Thelle DS, Mjøs OD. The Tromsø Heart-Study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977;1:965–8.
   PubMed Web of Science ®Google Scholar
• Assmann G, Funke H. HDL metabolism and atherosclerosis. J Cardiovasc Pharmacol 1990;16:15–20.
   PubMed Web of Science ®Google Scholar
• Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PWF, Salem DN, Schaefer EJ. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85:2025–33.
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PWF. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994;35:871–82.
   PubMed Web of Science ®Google Scholar
• Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagündüz P, Ozbayrakçi S, Gökdemir O, Mahley RW. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, non-obese Turkish population. J Lipid Res 1999;40:432–8.
   PubMed Web of Science ®Google Scholar
• Maugeais C, Tietge UJ, Broedl UC, Marchadier D, Cain W, McCoy MG, Lund-Katz S, Glick JM, Rader DJ. Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase. Circulation 2003;28;108: 2121–6.
   Google Scholar
• Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 2006;3:e22.
   PubMed Web of Science ®Google Scholar
• Hirano T, Nohtomi K, Koba S, Muroi A, Ito Y. A simple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. J Lipid Res 2008;49:1130–6.
   PubMed Web of Science ®Google Scholar
• Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract 2012;18:1:1–78.
   PubMedGoogle Scholar
• Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373–81.
   PubMed Web of Science ®Google Scholar
• Yu S, Yarnell JW, Sweetnam P, Bolton CH. High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study. Atherosclerosis 2003;166:331–8.
   Google Scholar
• Ruotolo G, Ericsson CG, Tettamanti C, Karpe F, Grip L, Svane B, Nilsson J, de Faire U, Hamsten A. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). J Am Coll Cardiol 1998;32:1648–56.
   PubMed Web of Science ®Google Scholar
• Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006;113:1556–63.
   PubMed Web of Science ®Google Scholar
• Ikewaki K, Rader DJ, Sakamoto T, Nishiwaki M, Wakimoto N, Schaefer JR, Ishikawa T, Fairwell T, Zech LA, Nakamura H. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest 1993;92:1650–8.
   PubMed Web of Science ®Google Scholar
• Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi K, Takami S, Menju M. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 1995;15:1849–56.
   PubMed Web of Science ®Google Scholar
• Barter PJ, Caulfield M, Eriksson M, Grundy SM. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109–22.
   PubMed Web of Science ®Google Scholar
• Tall AR, Yvan-Charvet L, Wang N. The failure of torcetrapib: was it the molecule or the mechanism?Arterioscler Thromb Vasc Biol 2007;27:257–60.
   PubMed Web of Science ®Google Scholar
• , AIM-HIGH InvestigatorsBoden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255–67.
   PubMed Web of Science ®Google Scholar
• Morgan JM, Carey CM, Lincoff A, Capuzzi DM. The effects of niacin on lipoprotein subclass distribution. Prev Cardiol 2004;7:182–7.
   PubMedGoogle Scholar
• Demacker PN, Hak-Lemmers HL, Hijmans AG, Baadenhuysen H. Evaluation of the dual-precipitation method for determination of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in serum. Clin Chem 1986;32:819–25.
   PubMed Web of Science ®Google Scholar
• Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. Lipid Res 1982;23:1206–23.
   PubMed Web of Science ®Google Scholar
• Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005;96:1221–32.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J 2010;74: 2263–70.
   PubMed Web of Science ®Google Scholar
• Annema W, Tietge UJ. Role of hepatic lipase and endothelial lipase in high-densitylipoprotein-mediated reverse cholesterol transport. Curr Atheroscler Rep 2011;13:257–65.
   PubMed Web of Science ®Google Scholar
• Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, South V, Amin D, Perrone M, Rader DJ. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999;21:424–8.
   PubMed Web of Science ®Google Scholar
• Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, Cooper AD, Quertermous T. Endothelial lipase is a major determinant of HDL level. J Clin Invest 2003;111:347–55.
   PubMed Web of Science ®Google Scholar